Follow The Filings

IRTC Irhythm Technologies Inc.

Health Care, filed as IRHYTHM TECHNOLOGIES INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 0.0%
  • $22M
  • 1 reduce

In 2026 Q2 Ron Baron trimmed Irhythm Technologies.

Who owns this now

Largest portfolio weights among holders, up to 0.0% (Ron Baron, Bamco Inc. (Baron Capital)). Not free-float ownership.

  1. Ron Baron Reduce 0.03%

Who owns IRTC

Sorted by value, long equity only, as of 2026 Q2.

History
Ron Baron, Bamco Inc. (Baron Capital) 0.03%, was 0.06% Reduce −1.3% 181,430 $22M History

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by IRTC's executives, directors and 10% owners in the last 12 months, from their Form 4s

All IRTC insider trades
  • $57K bought by 1 insider
  • None no sales outside a trading plan
  • $4.5M sold by 5 insiders under 10b5-1 plans
  1. Abhijit Y Talwalkar Director
    Planned sale
    $626K 5,312 shares at $117.93 21% of stake
    Traded May 11 Filed May 12
  2. Abhijit Y Talwalkar Director
    Buy
    $57K 5,312 shares at $10.71 +26% to stake
    Traded May 11 Filed May 12
  3. Mervin Smith EVP Strategic Business Ops
    Planned sale
    $295K 2,585 shares at $114.30 10% of stake
    Traded Mar 16 Filed Mar 17
  4. Mervin Smith EVP Strategic Business Ops
    Planned sale
    $103K 732 shares at $140.91 4.6% of stake
    Traded Feb 24 Filed Feb 25
  5. Marc Wade Rosenbaum Chief Accounting Officer
    Planned sale
    $39K 280 shares at $140.91 2.6% of stake
    Traded Feb 24 Filed Feb 25
  6. Abhijit Y Talwalkar Director
    Planned sale
    $774K 5,312 shares at $145.70 21% of stake
    Traded Feb 23 Filed Feb 24
  7. Chad Patterson Chief Comm & Product Officer
    Planned sale
    $52K 280 shares at $184.83 0.6% of stake
    Traded Dec 2, 2025 Filed Dec 3, 2025
  8. Abhijit Y Talwalkar Director
    Planned sale
    $925K 5,312 shares at $174.13 21% of stake
    Traded Nov 10, 2025 Filed Nov 12, 2025
  9. Daniel G. Wilson CFO
    Planned sale
    $1.7M 8,000 shares at $207.44 23% of stake
    Traded Oct 31, 2025 Filed Nov 3, 2025

Also filed in the last 12 months, not counted as buying or selling: 46 sales to cover taxes, 40 stock grants, and 2 option exercises.

SEC filings

Recent issuer filings from EDGAR, 14 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
8-K 7.01,9.01
8-K 7.01
SCHEDULE 13G/A —
SCHEDULE 13G —
8-K 5.02
8-K 1.01,2.02,7.01,9.01
8-K 1.01,3.02,9.01
10-Q
8-K 1.05
8-K 7.01,9.01
8-K 5.02,5.07,9.01
SCHEDULE 13G —
SCHEDULE 13G/A —

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $492.68M $591.84M $747.14M
Gross profit $331.81M $407.53M $527.25M
Gross margin * 67.3% 68.9% 70.6%
Net income -$123.41M -$113.29M -$44.55M
Net margin * -25.0% -19.1% -6.0%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $230.81M $645.82M $702.76M
Total non-current assets * $202.33M $285.63M $317.28M
Total assets $0.433B $0.931B $1.02B
Total current liabilities $107.37M $110.92M $151.89M
Total non-current liabilities * $115.68M $729.62M $715.41M
Total equity $210.1M $90.91M $152.75M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$50.1M $3.39M $80.86M
Cash from investing -$1.21M -$122.98M -$277.06M
Cash from financing $8.82M $511.38M $12.61M
Net change in cash -$42.66M $391.78M -$183.58M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.